´ëÇѺÎÀÎÁ¾¾çÇÐȸ Chemo-TIP Review Course 2023 : 2023-01-14 |
|
´ëÇѺÎÀÎÁ¾¾çÇÐȸ Chemo-TIP Review Course 2023 : 2023-01-14 ±³À°ÀÏÀÚ : 2023-01-14 ±³À°Àå¼Ò : °¡Å縯´ëÇб³ ¼ºÀDZ³Á¤ ¸¶¸®¾ÆȦ ±³À°ÁÖÁ¦ : Chemo-TIP Review Course 2023 ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ ´ã´çÀÚ : ÁöÀºÁ¤ ¿¬¶ôó : 02-512-5915 À̸ÞÀÏ : gyncancer@gyncancer.or.kr ±³À°Á¾·ù : »êºÎÀΰú Âü¼®¿¹»óÀοø : 150¸í Èñ¸ÁÆòÁ¡ : 6Á¡ Áö¿ª : ¼¿ïƯº°½Ã ±³À°½Ã°£ : 6 ½Ã°£ 5ºÐ ¼¼ºÎ¼ö°·á : 80,000¿ø ºñ°í Àü¹®ÀÇ 80,000 ¿ø / Àü°øÀÇ 60,000 ¿ø / ¿¬±¸¿ø°£È£»ç 40,000 ¿ø / ¸¸ 65¼¼ÀÌ»ó, Ã⿬Áø ¹«·á ±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 09:00~09:15 Ovarian cancer I (first-line) ±è¼¼ÀÍ(¼¿ïÀÇ´ë) ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 09:15~09:30 Ovarian cancer II (second- line and beyond) ÃÖÀ±Áø(°¡Å縯ÀÇ´ë) ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 09:30~09:50 Uterine cancer Á¶Çö¿õ(°í·ÁÀÇ´ë) ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 09:50~10:10 Cervical cancer ³ëÁØÈ£(¼º±Õ°üÀÇ´ë) Åä·Ð 01-14 ¸¶¸®¾ÆȦ 10:10~10:20 Q&A () ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 10:20~10:40 Concepts for RECIST/iRECIST criteria ½É¿µ¼·(°¡ÃµÀÇ´ë) ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 10:40~11:00 Application to real patients: case review À̽ÅÈ(¿ï»êÀÇ´ë) ÈÞ½Ä 01-14 11:00~11:20 Coffee break () ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 11:20~11:35 Targeted agents ¼³¾Ö¶õ(°í·ÁÀÇ´ë) ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 11:35~11:50 PARP inhibitors ±è³»¸®(¼¿ïÀÇ´ë) ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 11:50~12:05 Immuno-oncologics ¹ÚÁؽÄ(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 12:05~12:20 Conventional cytotoxic agents ÀÌÀºÁö(Áß¾ÓÀÇ´ë) Åä·Ð 01-14 ¸¶¸®¾ÆȦ 12:20~12:30 Q&A () ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 12:30~12:45 How to use visanne to control endometriosis? À̹æÇö(ÀÎÇÏÀÇ´ë) ½Ä»ç 01-14 12:45~13:30 Lunch () ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 13:30~13:50 Application of biomarker testing ÃÖ¹Îö(Â÷ÀÇ´ë) Åä·Ð 01-14 ¸¶¸®¾ÆȦ 13:50~14:20 Panel discussion, Q&A ±èÇö¼ö±èÈ¿Áø/¿ìÇÏ¿µ(¼º±Õ°üÀÇ´ë/¼¿ïÀÇ´ë/¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 14:20~14:40 °³Á¤µÈ Ç×¾Ï °ø°í¾È (2022.8.1) ÀÓÇöÁö(¼¿ïÀÇ´ë) ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 14:40~15:00 ½ÇÁ¦ º¸Çè½É»ç »ç·Ê ¹× ÁÖÀÇ»çÇ× ±è»óÈñ/ÀÌÀº¼Ø/ÃÖ¼±Èñ(»ï¼º¼¿ïº´¿ø/½ÅÃ̼¼ºê¶õ½ºº´¿ø/ºÐ´ç¼¿ï´ëº´¿ø) ÈÞ½Ä 01-14 15:00~15:20 Coffee break () ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 15:20~15:40 How to manage ovarian cancer patients ÀÌÁ¤À±(¿¬¼¼ÀÇ´ë) ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 15:40~16:00 How to manage uterine cancer patients ÀÌÀ¯¿µ(¼º±Õ°üÀÇ´ë) ±³À°½Ã°£ 01-14 ¸¶¸®¾ÆȦ 16:00~16:20 How to manage cervical cancer patients ¹ÚÁ¤¿(¿ï»êÀÇ´ë) Åä·Ð 01-14 ¸¶¸®¾ÆȦ 16:20~16:30 Q&A () |
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|